Aortic banding in rat as a model to investigate malnutrition associated with heart failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Héliès Toussaint, Cécile ^a   Moinard, Christophe ^b   Rasmusen, Carole ^b   Tabbi Anneni, Imène ^a   Cynober, Luc ^b   Grynberg, Alain ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Faculte de Pharmacie   (France)

Author keywords

Amino acids; Cachexia; Multi organ failure

Indexed keywords

AMINO ACID; BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CHRONIC DISEASE; CITRULLINEMIA; CONTROLLED STUDY; DEVELOPED COUNTRY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HYPOTROPHY; KIDNEY FAILURE; LIVER DYSFUNCTION; MALE; MALNUTRITION; MULTIPLE ORGAN FAILURE; MUSCLE ATROPHY; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONTENT; RAT; SURVIVAL TIME; UREMIA;

AMINO ACIDS; ANIMALS; AORTA; CREATINE KINASE; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; KIDNEY; LIGATION; LIVER; MALE; MALNUTRITION; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, WISTAR;

EID: 17844377954     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00320.2004     Document Type: Article

References (53)

1. Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, Dunn JF, Stratton J, Kemp GJ, Radda GK, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21: 1101-1106, 1993.
2. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, and Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 80: 299-305, 1989.
3. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, and Coats AJ. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96: 526-534, 1997.
4. Anker SD and Coats AJS. Cardiac cachexia - a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115: 836-847, 1999.
5. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, and Coats AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349: 1050-1053, 1997.
6. Bergstrom J and Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 32: 834-841, 1998.
7. Blanc MC, Neveux N, Laromiguiere M, Berard MP, and Cynober L. Evaluation of a newly available biochemical analyzer: the Olympus AU 600. Clin Chem Lab Med 38: 465-475, 2000.
8. Breuille D, Arnal M, Rambourdin F, Bayle G, Levieux D, and Obled C. Sustained modifications of protein metabolism in various tissues in a rat model of long-lasting sepsis. Clin Sci (Lond) 94: 413-423, 1998.
9. Cano N and Leverve XM. Influence of chronic liver disease and chronic renal failure on nutrient metabolism and undernutrition. Nutrition 13: 381-383, 1997.
10. Ceballos I, Chauveau P, Guerin V, Bardet J, Parvy P, Kamoun P, and Jungers P. Early alterations of plasma free amino acids in chronic renal failure. Clin Chim Acta 188: 101-108, 1990.
11. Christenson RH and Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem 44: 1855-1864, 1998.
12. Coats AJS. The "muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol 28: 2255-2262, 1996.
13. Curthoys NP. Cellular distribution and induction of the enzyme of renal ammoniagenesis and glucogenesis. In: pH Homeostasis: Mechanisms and Control, edited by Haussinger D. San Diego, CA: Academic, 1988, p. 323-336.
14. Cynober L. Amino acid metabolism in thermal burns. JPEN J Parenter Enteral Nutr 13: 196-205, 1989.
15. Cynober LA. Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18: 761-766, 2002.
16. Dagnelie P. Théories et Méthodes Statistiques. Belgium: Presses Agronomiques de Gembloux, 1975.
17. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, and Anker SD. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9: 29-35, 2003.
18. De Jonghe B, Appere-De-Vechi C, Fournier M, Tran B, Merrer J, Melchior JC, and Outin H. A prospective survey of nutritional support practices in intensive care unit patients: what is prescribed? What is delivered? Crit Care Med 29: 8-12, 2001.
19. Desjardins S, Mueller RW, and Cauchy MJ. A pressure overload model of congestive heart failure in rats. Cardiovasc Res 22: 696-702, 1988.
20. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, and Ventura-Clapier R. Subcellular creatine kinase alterations: implications in heart failure. Circ Res 85: 68-76, 1999.
21. Doehner W, Pflaum CD, Rauchhaus M, Godsland IF, Egerer K, Cicoira M, Florea VG, Sharma R, Bolger AP, Coats AJ, Anker SD, and Strasburger CJ. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 145: 727-735, 2001.
22. Druml W, Fischer M, Liebisch B, Lenz K, and Roth E. Elimination of amino acids in renal failure. Am J Clin Nutr 60: 418-423, 1994.
23. Echemann M, Alla F, Briancon S, Juilliere Y, Virion JM, Mertes PM, Villemot JP, Zannad F, Aliot E, Breton C, Khalif EK, Neimann JL, Allam S, Admant P, Baille N, Bellanger P, D'Hotel R, Dambrine P, Dodet JF, Graille M, Kessler M, Rebeix G, Royer Saulnier JP, Thisse JY, Trutt B, Vidal P, Vuillemin MC, Delahaye Ducimetiere P, Fagnani F, and Guize L. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study). Eur J Heart Fail 4: 647-654, 2002.
24. Feldman AM, Weinberg EO, Ray PE, and Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73: 184-192, 1993.
25. Felgines C, Savanovitch C, Farges MC, Cynober L, and Vasson MP. Protein metabolism in rats during long-term dietary restriction: influence of aging. JPEN J Parenter Enteral Nutr 23: 32-37, 1999.
26. Filippatos GS, Tsilias K, Venetsanou K, Karambinos E, Manolatos D, Kranidis A, Antonellis J, Kardaras F, Anthopoulos L, and Baltopoulos G. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-α system. Int J Cardiol 76: 117-122, 2000.
27. Fleury P and Aberham R. Recherche sur le dosage des protéines par la méthode photométrique du Biuret selon la technique de Gornall. Ann Biol Clin (Paris) 9: 453-466, 1951.
28. Garibotto G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. Nutrition 15: 145-155, 1999.
29. Gore DCWRR. Metabolic response of muscle to alanine, glutamine, and valine supplementation during severe illness. J Parent Ent Nutr 27: 307-314, 2003.
30. Hasselgren PO, Hall-Angeras M, Angeras U, Benson D, James JH, and Fischer JE. Regulation of total and myonbrillar protein breakdown in rat extensor digitorum longus and soleus muscle incubated flaccid or at resting length. Biochem J 267: 37-44, 1990.
31. Haussinger D, Meijer S, Gerok W, and Sies H. Hepatic nitrogen metabolism and acid-base homeostasis. In: pH Homeostasis: Mechanisms and Control, edited by Haussinger D. San Diego, CA: Academic, 1988, p. 337-377.
32. Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, Ashida T, Sugiyama T, Hada Y, Kuwajima I, Nishinaga M, Akioka H, Nakajima O, Nagai R, and Yazaki Y. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 51: 585-591, 2001.
33. Jacobsson A, Pihl-Lindgren E, and Fridlund B. Malnutrition in patients suffering from chronic heart failure; the nurse's care. Eur J Heart Fail 3: 449-456, 2001.
34. Leverve XM. amino acid metabolism and gluconeogenesis. In: Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton, FL: CRC, 1995, p. 45-55.
35. Levillain O, Marescau B, Possemiers I, Al Banchaabouchi M, and De Deyn PP. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Pflügers Arch 442: 558-569, 2001.
36. Levillain O, Parvy P, and Hassler C. Amino acid handling in uremic rats: citrulline, a reliable marker of renal insufficiency and proximal tubular dysfunction. Metabolism 46: 611-618, 1997.
37. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, and Coats AJ. Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 19: 1547-1551, 1998.
38. Michielsen PP, Hauben EI, Ramon AM, Van Marck EA, and Pelckmans PA. Serum aminotransferase levels and histological disease in chronic hepatitis C. Acta Gastroenterol Belg 60: 11-14, 1997.
39. Minet-Quinard R, Moinard C, Villie F, Walrand S, Vasson MP, Chopineau J, and Cynober L. Kinetic impairment of nitrogen and muscle glutamine metabolisms in old glucocorticoid-treated rats. Am J Physiol Endocrinol Metab 276: E558-E564, 1999.
40. Minet-Quinard R, Moinard C, Walrand S, Villie F, Normand B, Vasson MP, Chopineau J, and Cynober L. Induction of a catabolic state in rats by dexamethasone: dose or time dependency? JPEN J Parenter Enteral Nutr 24: 30-36, 2000.
41. Momken I, Kahapip J, Bahi L, Badoual T, Hittinger L, Ventura-Clapier R, and Veksler V. Does angiotensin-converting enzyme inhibition improve the energetic status of cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol 35: 399-407, 2003.
42. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, and McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 82: 352-356, 1999.
43. Norton JA, Gorschboth CM, Wesley RA, Burt ME, and Brennan MF. Fasting plasma amino acid levels in cancer patients. Cancer 56: 1181-1186, 1985.
44. Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, and Jalan R. Interorgan ammonia metabolism in liver failure. Neurochem Int 41: 177-188, 2002.
45. Rousseau D, Helies-Toussaint C, Raederstorff D, Moreau D, and Grynberg A. Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats. Mol Cell Biochem 225: 109-119, 2001.
46. Sole MJ and Jeejeebhoy KN. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care 3: 417-424, 2000.
47. Sole MJ and Jeejeebhoy KN. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz 27: 174-178, 2002.
48. Tabbi-Anneni I, Helies-Toussaint C, Morin D, Bescond-Jacquet A, Lucien A, and Grynberg A. Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover? J Pharmacol Exp Ther 304: 1003-1009, 2003.
49. Van Kempen AAMW, Romijn JA, Ruiter AFC, Endert E, Weverling GJ, Kok JH, and Sauerwein HP. Alanine administration does not stimulate gluconeogenesis in preterm infants. Metabolism 52: 945-949, 2003.
50. Vasan R and Levy D. The progression from hypertension to heart failure: an overview of pathogenic mechanisms. In: Controversies in the Management of Heart Failure, edited by Coats A. New York: Churchill Livingstone, 1997.
51. Walrand S, Chambon-Savanovitch C, Felgines C, Chassagne J, Raul F, Normand B, Farges MC, Beaufrere B, Vasson MP, and Cynober L. Aging: a barrier to renutrition? Nutritional and immunologic evidence in rats. Am J Clin Nutr 72: 816-824, 2000.
52. Witte KK, Clark AL, and Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol 37: 1765-1774, 2001.
53. Zaha V, Grohmann J, Gobel H, Geibel A, Beyersdorf F, and Doenst T. Experimental model for heart failure in rats-induction and diagnosis. Thorac Cardiovasc Surg 51: 211-215, 2003.